The Newly Institute Provides Update on Proposed Arrangement and Certain Secured Indebtedness
Calgary, Alberta--(Newsfile Corp. - August 1, 2023) - The Newly Institute Inc. ("Newly" or the "Company") wishes to announce that,...
Addiction
Safe Supply Streaming Co. Closes Strategic Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 1, 2023) - Safe Supply Streaming Co. Ltd. ("Safe Supply" or "SSSC" or "the...
Clearmind Medicine Files Patent Application with USPTO for the Treatment of Dyskinesia; Further Strengthens its Already Robust IP Portfolio
Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
Avenue Therapeutics Announces High Potency and Full Efficacy in a Model of Generalized Seizures for its Novel GABA-A Receptor Potentiator, BAER-101, Supporting Phase 2 Clinical Study
-A Phase 2a study of BAER-101 in epilepsy is planned to initiate in 2024MIAMI, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
Awakn Life Sciences Completes Sale of Awakn Clinics In Norway
Sale Completes Awakn's Exit From Healthcare Services To Focus Solely on Biotechnology Research and DevelopmentToronto, Ontario--(Newsfile Corp. - August 1,...
C4X Discovery Holdings PLC Announces Divestment of Orexin-1 to Indivior for £15.95m
This announcement contains inside informationStrategic Divestment of C4XD's Orexin-1 Receptor Antagonist Programme to Indivior for £15.95 MillionSale encompasses all rights...
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
OKYO plans a 40-patient OK-101 open-label clinical trial with Dr Pedram Hamrah, Tufts Medical Center, as Principal Investigator, a leading...
Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering
CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical...
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
Company to receive $2 million in upfront payments, with the potential to receive up to $50 million in milestone payments...
Solo-Dex, Inc. Strikes Groundbreaking Master Distributor Agreement with CH Trading Group LLC and Farouk, Maamoun Tamer & Co. for the Distribution of its Fascile(R) Non-Opioid Acute Pain Management Suite in the Kingdom of Saudi Arabia
WOLF CREEK, MT / ACCESSWIRE / July 26, 2023 / Solo-Dex, a leading player in the development, manufacture, and sales...
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
TORONTO, ON / ACCESSWIRE / July 26, 2023 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage...
BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023
BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Odyssey Unveils Rebrand of Eating Disorder Outpatient Clinics to Support Strategic Vision and Accelerated Growth
Continuing to provide a full spectrum of eating disorder treatment, four Selah House Outpatient clinics have rebranded as Aster Springs...
Tonix Pharmaceuticals Announces Data Supporting the Memory- and Cognition-Enhancing Effects of Racemic Tianeptine and (S)-Tianeptine, but not (R)-Tianeptine, in the In Vivo Rat Novel Object Recognition (NOR) Test
New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric...
Jovive Health Receives LegitScript Certification for Medication-Assisted Treatment Services
Jovive Health is recognized with industry-leading certification for treating patients with opioid use disorder.EMERYVILLE, CA / ACCESSWIRE / July 19,...
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Banyan Treatment Centers Names John Sory as Chief Executive Officer
Founder Joe Tuttle Becomes Board DirectorPOMPANO BEACH, Fla.--(BUSINESS WIRE)--Banyan Treatment Centers, LLC. (“Banyan Treatment Centers” or “Banyan”), the leading network...
Neural Therapeutics Inc. Closes Rights Offering
Toronto, Ontario--(Newsfile Corp. - July 14, 2023) - Neural Therapeutics Inc. (the "Company" or "Neural"), an ethnobotanical drug-discovery and development...
Curated Mental Health Emphasizes the Importance of Professional Support in Psychedelic Therapy for Optimal Mental Health Outcomes
NEW YORK, NY / ACCESSWIRE / July 14, 2023 / Is ketamine a powerful tool for therapeutic purposes? Absolutely. But...
The Newly Institute Inc. Provides Update on Proposed Arrangement and Short-Term Forbearance on Repayment of Certain Secured Indebtedness
Calgary, Alberta--(Newsfile Corp. - July 13, 2023) - The Newly Institute Inc. ("Newly" or the "Company") wishes to announce that...